Core A: Administrative Core

核心A:行政核心

基本信息

  • 批准号:
    10362704
  • 负责人:
  • 金额:
    $ 8.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-03 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT The Administrative Core (Core A) will provide overall oversight of the research proposed within this P01 Program Project. Core A is directed by Dr. Pawel Kalinski, the Principal Investigator of this Program. Dr. Kalinski has direct work experience at the two participating institutions, Roswell Park Comprehensive Cancer Center (RPCI; since February 2017) and the University of Pittsburgh (2000-2017). Dr. Kalinski will be assisted by Ms. Judith Epstein, Director of Grant and Foundation Development at Roswell Park who will serve as the overall P01 Program Manager providing Program oversight and coordination of interactions and communications. The P01 Executive Committee will be composed of the leaders of the P01 Projects and Cores. Core A will be responsible for the overall supervision of the research within this Program Project performed at Roswell Park and the University of Pittsburgh, data dissemination between its participants and to outside entities, oversight of the Cores, the interactions with NCI and the Internal and External Advisors, along with interactions with parallel program projects at Roswell Park and the University of Pittsburgh. Core A will organize the quarterly meetings to review of Program progress, along with the Annual P01 Retreats. It will closely interact with all Research Projects and all Cores of this highly-translational P01, and it will work particularly closely with Core C (Clinical) to assure optimal integration of the clinical and laboratory aspects of this clinically-oriented research program. The Administrative Core has the following Specific Aims: 1) Financial management and Program grant administration; 2) Coordination of interactions and Program meetings among the groups involved in the Program; 3) Sharing of data and experience with other Program Projects at Roswell Park and the University of Pittsburgh; 4) Integration of this Program with the clinical programs and existing shared resource cores at Roswell Park and the University of Pittsburgh; 5) Coordination of Program meetings and facilitation of interactions with the Internal and External Advisory Boards; 5) Communication with NIH/NCI, including the preparation of annual progress reports and the and final Program Project report; and 6) Data dissemination to other groups at Roswell Park, the University of Pittsburgh, outside partners and the scientific community and general public.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pawel Kalinski其他文献

Pawel Kalinski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pawel Kalinski', 18)}}的其他基金

Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
靶向趋化因子系统使肿瘤对免疫疗法敏感
  • 批准号:
    10362635
  • 财政年份:
    2020
  • 资助金额:
    $ 8.95万
  • 项目类别:
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
项目1:组合佐剂促进结直肠癌瘤内CTL的均匀和选择性浸润
  • 批准号:
    10362700
  • 财政年份:
    2020
  • 资助金额:
    $ 8.95万
  • 项目类别:
IRP-3
IRP-3
  • 批准号:
    10171149
  • 财政年份:
    2013
  • 资助金额:
    $ 8.95万
  • 项目类别:
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
alphaDC1 对卵巢癌的 MHC 限制性和 MHC 非限制性靶向
  • 批准号:
    8485810
  • 财政年份:
    2013
  • 资助金额:
    $ 8.95万
  • 项目类别:
IRP-3
IRP-3
  • 批准号:
    10473682
  • 财政年份:
    2013
  • 资助金额:
    $ 8.95万
  • 项目类别:
Administrative, Statistical, and Regulatory
行政、统计和监管
  • 批准号:
    8518924
  • 财政年份:
    2012
  • 资助金额:
    $ 8.95万
  • 项目类别:
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
结直肠癌与黑色素瘤的肿瘤特异性趋化因子调节
  • 批准号:
    8518921
  • 财政年份:
    2012
  • 资助金额:
    $ 8.95万
  • 项目类别:
Directing Tumor-specific T cells to Tumors
将肿瘤特异性 T 细胞引导至肿瘤
  • 批准号:
    8248336
  • 财政年份:
    2009
  • 资助金额:
    $ 8.95万
  • 项目类别:
Directing Tumor-specific T cells to Tumors
将肿瘤特异性 T 细胞引导至肿瘤
  • 批准号:
    8469287
  • 财政年份:
    2009
  • 资助金额:
    $ 8.95万
  • 项目类别:
Directing Tumor-specific T cells to Tumors
将肿瘤特异性 T 细胞引导至肿瘤
  • 批准号:
    8518920
  • 财政年份:
    2009
  • 资助金额:
    $ 8.95万
  • 项目类别:

相似海外基金

Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
  • 批准号:
    LP230100156
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
  • 批准号:
    EP/Y024168/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
  • 批准号:
    BB/Y008332/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Research Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
  • 批准号:
    10106787
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Launchpad
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
  • 批准号:
    2419731
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Standard Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
  • 批准号:
    2330663
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Standard Grant
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
  • 批准号:
    2421022
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Standard Grant
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
  • 批准号:
    2344389
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
  • 批准号:
    BB/Y008456/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Research Grant
Development of magnetic force biotechnology to facilitate neural regeneration
开发磁力生物技术促进神经再生
  • 批准号:
    EP/X014126/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了